Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F6A9W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,592
Award facts
- Contract value 100% obligated
- $28,592.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $28,592.33 delivery order to Amerisourcebergen Drug Corp on May 28, 2026, for RINVOQ ER 15 mg tablets (30-count units), with final completion by May 29, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying medications and medical devices to federal healthcare systems and the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26F6A9W?
SPE2DR26F6A9W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 28, 2026.
How much is contract SPE2DR26F6A9W worth?
The government has obligated $28,592 on SPE2DR26F6A9W.
Is contract SPE2DR26F6A9W an order under another contract?
Yes. SPE2DR26F6A9W is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F6A9W competed?
The extent of competition for SPE2DR26F6A9W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award